Matthew Vincent Dolan, EVP Strategy and Corporate Dev: Dexcom DXCM Sell · Filed 24/04/16

Trade details

Type: Insider sale
Amount: $274,241.9
Shares · price: 1,990 sh · $137.81 a share
Held after: 42,377 sh
Stock: Dexcom DXCM
Person: Matthew Vincent DolanEVP Strategy and Corporate Dev
Trade date: 24/04/15
Filed: 24/04/16
Days to filing: 1 days

Sold 4.5% of holdings

Share of holding sold: 4.5%

Dexcom trades, last 26 weeks

What else happened in Dexcom around then

Filed or reported within 30 days of the trade day · 24/03/16~24/05/15

Matthew Vincent Dolan's recent trades

Matthew Vincent DolanEVP, Strategy & Corporate Dev
SellDexcom
Sell
Dexcom
DXCM
$102.8K
1,183 sh
$102.8K
Filed 25/01/30
Traded 25/01/29
Matthew Vincent DolanEVP Strategy and Corporate Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$306.7K
2,423 sh
$306.7K
Filed 24/05/16
Traded 24/05/15
Matthew Vincent DolanEVP Strategy & Corp Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$243.6K
1,886 sh
$243.6K
Filed 24/03/19
Traded 24/03/15
Matthew Vincent DolanEVP Strategy & Corp Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$171.8K
1,314 sh
$171.8K
Filed 24/03/19
Traded 24/03/15
Matthew Vincent DolanEVP Strategy & Corp Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$131.8K
1,003 sh
$131.8K
Filed 24/03/19
Traded 24/03/15